|
Volumn 2, Issue 7, 2011, Pages 650-654
|
Carbocyclic 5′-nor "reverse" fleximers. Design, synthesis, and preliminary biological activity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 [4' HYDROXY 2' CYCLOPENTEN 1' YL] 5 (FURAN 2 YLL)URACIL;
1 [4' HYDROXY 2' CYCLOPENTEN 1' YL] 5 (THIAZOL 5 YL)URACIL;
1 [4' HYDROXY 2' CYCLOPENTEN 1' YL] 5 (THIOPHENE 2 YL)URACIL;
ANTIVIRUS AGENT;
CARBOCYCLIC NUCLEOSIDE;
DRUG METABOLIZING ENZYME;
NUCLEOSIDE DERIVATIVE;
PURINE;
PYRIMIDINE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTIVIRAL ACTIVITY;
ARTICLE;
CHEMICAL MODIFICATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
NONHUMAN;
PRIORITY JOURNAL;
|
EID: 79960154798
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c1md00094b Document Type: Article |
Times cited : (20)
|
References (21)
|